top of page
Stock Ticker Board



We are committed to provide plant product that is safe to use for medical purpose, recreational purpose and in agriculture sector.

To provide full-spectrum DNA testing, low temperature storage of various horticultural plants; extraction of plant product mainly CBD oil and to deliver unparalleled laboratory-based services to the North American agricultural sector.


With an immediate future focus on human cannabis products development derived from years of our executives research, knowledge and experience on animals and people.

Pharmagreen is a biotech sciences company with sales of nutraceutical products utilizing proprietary blends of natural medicinal plant and fungi. The company provides addition consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOP's for cultivation and live storage of any plant species services.

The company is currently developing its business opportunities within the United States.

The company is currently traded on the OTC Markets under the symbol PHBI



These forward-looking statements include, but are not limited to, statements regarding benefits of the proposed license, expected synergies,
anticipated future financial and operating performance and results, including estimates of growth. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. For example, the expected timing and likelihood of completion of the pending transaction, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the pending transaction that could reduce anticipated benefits or cause the parties to abandon the transaction, the ability to successfully integrate the businesses, the occurrence of any event, change or other circumstance that could give rise to the termination of the negotiations, the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Pharmagreen’s common stock. All such factors are difficult to predict and are beyond our control. We disclaim and do not undertake any obligation to update or regulations.

Investors should always conduct their own due diligence on any company when considering whether or not to make an investment. Claims of past performance are no guarantee of future performance. Apart from the general information that is published about the company on this
website, the Company may sometimes provide its own opinions about the industries and markets it does business in, all opinions are the
Company. Neither the general information nor opinions should be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions investors may make concerning the company are solely the responsibility of the investor based on personal due diligence. This website is provided only as an advertisement and informational aid, and as a starting point for doing additional independent research. It is also recommended, as a general rule, that before investing in any security a professional financial planner or advisor be consulted, and a complete and independent investigation should be conducted before investing in any security after prudent consideration of all pertinent risks. This website is not an offer to buy or sell a security.

bottom of page